JPRN-UMIN000015566CompletedPhase 1
Phase I study of neo-adjuvant chemoradiation therapy for newly diagnosed malignant astrocytomas - neoadjuvant chemoradiation for malignant astrocytomas
Chiba Cancer Center0 sites20 target enrollmentStarted: November 1, 2014Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •large tumor (>6cm) sign of tent-herniation existence of extracranial malignant tumor pregnancy psychological disorder HIV positive patients history of pneumonitis history of radiation therapy for intracranial lesions
Investigators
Similar Trials
Recruiting
Not Applicable
A phase I/II study of neoadjuvant chemoradiotherapy for pancreatic cancer.Pancreatic cancerJPRN-UMIN000042932The Jikei University school of medicine58
Completed
Not Applicable
Phase II study of neoadjuvant chemoradiotherapy of s-1 and cisplatin for advanced gastric cancer with lymph node metastases (Neo-KOGC04 study)Advanced Gastric CancerJPRN-UMIN000014331School of Medicine, Keio University30
Not yet recruiting
Not Applicable
eoadjuvant chemoradiotherapy with protons for resectable esophageal cancerKCT0005576ational Cancer Center68
Recruiting
Phase 1
Phase I, II study of neoadjuvant chemotherapy with gemcitabine and nab-paclitaxel for resectable pancreatic cancerpancreatic ductal cancerJPRN-jRCTs021200003Ishido Keinosuke30
Active, not recruiting
Not Applicable
PHASE II STUDY OF NEOADJUVANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED RECTAL CANCER - XELOXARTrectal cancerMedDRA version: 6.1Level: PTClassification code 10062099EUCTR2005-005661-11-ITAZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO